177 related articles for article (PubMed ID: 33838572)
21. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological analysis of 22 Müllerian adenosarcomas and the sequencing of DICER1 mutation.
Yao X; Wang W; He Y
Diagn Pathol; 2024 Apr; 19(1):56. PubMed ID: 38570882
[TBL] [Abstract][Full Text] [Related]
23. Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.
Park JY; Baek MH; Park Y; Kim YT; Nam JH
Virchows Arch; 2018 Jul; 473(1):61-69. PubMed ID: 29869299
[TBL] [Abstract][Full Text] [Related]
24. Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas.
Kurihara S; Oda Y; Ohishi Y; Kaneki E; Kobayashi H; Wake N; Tsuneyoshi M
Mod Pathol; 2010 Feb; 23(2):225-34. PubMed ID: 19898427
[TBL] [Abstract][Full Text] [Related]
25. Endometrial stromal sarcomas: immunoprofile with emphasis on HMB45 reactivity.
Albores-Saavedra J; Dorantes-Heredia R; Chablé-Montero F; Chanona-Vilchis J; Pérez-Montiel D; Lino-Silva LS; González-Romo MA; Ramírez-Jaramillo JM; Henson DE
Am J Clin Pathol; 2014 Jun; 141(6):850-5. PubMed ID: 24838330
[TBL] [Abstract][Full Text] [Related]
26. Endometrial Stromal Sarcoma Arising from Endometrial Polyp: A Case Report.
Sato S; Ojima Y; Kanda M; Kizaki T; Ohara N
Kobe J Med Sci; 2018 Sep; 64(2):E36-E42. PubMed ID: 30381725
[TBL] [Abstract][Full Text] [Related]
27. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors.
Jakate K; Azimi F; Ali RH; Lee CH; Clarke BA; Rasty G; Shaw PA; Melnyk N; Huntsman DG; Laframboise S; Rouzbahman M
Mod Pathol; 2013 Jan; 26(1):95-105. PubMed ID: 22918161
[TBL] [Abstract][Full Text] [Related]
28. Endometrial stromal sarcoma--the new genetic paradigm.
Lee CH; Nucci MR
Histopathology; 2015 Jul; 67(1):1-19. PubMed ID: 25355621
[TBL] [Abstract][Full Text] [Related]
29. Endometrial stromal tumors: the new WHO classification.
Conklin CM; Longacre TA
Adv Anat Pathol; 2014 Nov; 21(6):383-93. PubMed ID: 25299308
[TBL] [Abstract][Full Text] [Related]
30. Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
Gadducci A; Multinu F; De Vitis LA; Cosio S; Carinelli S; Aletti GD
Gynecol Oncol; 2023 Apr; 171():95-105. PubMed ID: 36842409
[TBL] [Abstract][Full Text] [Related]
31. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract][Full Text] [Related]
32. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
33. DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing.
Apellaniz-Ruiz M; McCluggage WG; Foulkes WD
Genes Chromosomes Cancer; 2021 Mar; 60(3):217-233. PubMed ID: 33135284
[TBL] [Abstract][Full Text] [Related]
34. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma.
Balleine RL; Earls PJ; Webster LR; Mote PA; deFazio A; Harnett PR; Clarke CL
Int J Gynecol Pathol; 2004 Apr; 23(2):138-44. PubMed ID: 15084842
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of CD10 antigen in uterine adenosarcoma.
Amant F; Steenkiste E; Schurmans K; Verbist L; Abeler VM; Tulunay G; de Jonge E; Massuger L; Moerman P; Vergote I
Int J Gynecol Cancer; 2004; 14(6):1118-21. PubMed ID: 15571618
[TBL] [Abstract][Full Text] [Related]
36. LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies.
Li C; Wang C
J Zhejiang Univ Sci B; 2021 Aug; 22(8):633-646. PubMed ID: 34414699
[TBL] [Abstract][Full Text] [Related]
37. Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains.
Bhargava R; Shia J; Hummer AJ; Thaler HT; Tornos C; Soslow RA
Mod Pathol; 2005 Jan; 18(1):40-7. PubMed ID: 15309019
[TBL] [Abstract][Full Text] [Related]
38. Endometrial stromal sarcoma: clinicopathological and immunophenotype study of 18 cases.
Vera AA; Guadarrama MB
Ann Diagn Pathol; 2011 Oct; 15(5):312-7. PubMed ID: 21652246
[TBL] [Abstract][Full Text] [Related]
39. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]